FindTrial
Sign In

To assess the effect of takradhara in attention deficit hyperactivity disorder-A clinical study

To evaluate the efficacy of takradhara in attention deficit hyperactivity disorder - Nill

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070337
Enrollment
20
Registered
2024-07-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F902- Attention-deficit hyperactivity disorder, combined type

Interventions

None listed

Sponsors

BLDE Deemed To Be University Vijayapur Karnataka 586109
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children aged between 6-16 years of age 2.Children fulfilling the DSM-V criteria for diagnosis of ADHD. 3.Parents who are willing for treatment and giving concern

Exclusion criteria

Exclusion criteria: 1.Children under other medications or interventions such as behavior therapy are excluded from the study. 2.Children with mild to severe mental retardation, conduct disorders, Pervasive disorder and other Psychotic disorders are excluded. 3.Children with chronic ailments like tuberculosis, malignancy etc. are excluded.

Design outcomes

Primary

MeasureTime frame
Assessment in reduction of symptoms of ADHD by using DSM-V criteria in 12 weeksTimepoint: 12 weeks—

Secondary

MeasureTime frame
Improvement in symptoms of DSM-V check list within 12 weeksTimepoint: 12 weeks—

Countries

India

Contacts

Public ContactDr Doulabi M Choudhari

BLDEAs AVS Ayurveda Mahavidyalaya Hospital and Research Centre Vijayapur

choudharidoulabi@gmail.com8197378138

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026